The Indian Journal of Pediatrics

, Volume 80, Issue 11, pp 920–924 | Cite as

Topiramate and Propranolol for Prophylaxis of Migraine

  • Razieh Fallah
  • Mohammad Saleh Divanizadeh
  • Mehran Karimi
  • Mehrdad Mirouliaei
  • Ali Shamszadeh
Original Article
First Online:
Received:
Accepted:

Abstract

Objective

To compare efficacy and safety of topiramate (TPM) and propranolol for migraine prophylaxis in children.

Methods

In a parallel single-blinded randomized clinical trial, 5–15 y-old referred migraineurs to Pediatric Neurology Clinic of Shahid Sadoughi Medical Sciences University, Yazd, Iran from May through October 2011, were evaluated. Patients were distributed into two groups, 50 of whom were treated with 3 mg/kg/d of topiramate (TPM) and another group of 50, were treated with 1 mg/kg of propranolol for 3 mo. Primary endpoints were efficacy in reduction of monthly frequency, severity, duration and headache related disability. Secondary outcome was clinical side effects.

Results

Fifty two girls and 48 boys with mean age of 10.34 ± 2.31 y were evaluated. Monthly frequency, severity and duration of headache decreased with TPM, from 13.88 ± 8.4 to 4.13 ± 2.26 attacks, from 6.32 ± 1.93 to 2.8 ± 2.12, and from 2.36 ± 1.72 to 0.56 ± 0.5 h, respectively. Monthly frequency, severity and duration of headache also decreased with propranolol from 16.2 ± 6.74 to 8.8 ± 4.55 attacks, from 6.1 ± 1.54 to 4.8 ± 1.6 and from 2.26 ± 1.26 to 1.35 ± 1.08 h, respectively. Pediatric Migraine Disability Assessment score reduced from 31.88 ± 9.72 to 9.26 ± 7.21 with TPM and from 33.08 ± 8.98 to 23.64 ± 9.88 with propranolol. Transient mild side effects were seen in 18 % of TPM and in 10 % of propranolol (P = 0.249) groups.

Conclusions

Topiramate is more effective than propranolol for pediatric migraine prophylaxis.

Keywords

Headache Migraine Prophylaxis Topiramate Propranolol 
This is a preview of subscription content, log in to check access.

Notes

Conflict of Interest

None.

Role of Funding Source

This study was funded by a grant from the Research Deputy of Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

References

  1. 1.
    Hershey AD. Migraine. In: Kliegman RM, Stanton BF, Schor NF, St. Geme JW, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders; 2011. pp. 2040–5.Google Scholar
  2. 2.
    Oleson J. The International Classification of Headache Disorders: 2nd ed. Headache classification subcommittee of the International Headache Society. Cephalalgia. 2004;24:9–160.CrossRefGoogle Scholar
  3. 3.
    Hershey AD, Winner PK. Pediatric migraine: recognition and treatment. J Am Osteopath Assoc. 2005;105:2S–8S.PubMedGoogle Scholar
  4. 4.
    Fallah R. Topiramate as a new antiepileptic drug in epileptic children in Iran. Indian J Pediatr. 2006;73:1073–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Jayapal S, Maheshwari N. Question 3. Topiramate for chronic migraine in children. Arch Dis Child. 2011;96:318–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Cruz MJ, Valencia I, Legido A, et al. Efficacy and tolerability of topiramate in pediatric migraine. Pediatr Neurol. 2009;41:167–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Hershey AD, Powers SW, Vockell ALB, LeCates SL, Kabbouche MA, Maynard MK. PedMIDAS: Development of a questionnaire to assess disability of migraines in children. Neurology. 2001;57:2034–9.Google Scholar
  8. 8.
    Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13:227–36.PubMedCrossRefGoogle Scholar
  9. 9.
    Ashtari F, Shaygannejad V, Akbari M. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis. Acta Neurol Scand. 2008;118:301–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50:109–15.PubMedCrossRefGoogle Scholar
  11. 11.
    Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593–7.PubMedGoogle Scholar
  12. 12.
    Forsythe WI, Gillies D, Sills MA. Propanolol (‘Inderal’) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26:737–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate pediatric migraine study investigators. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45:1304–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Lewis D, Winner P, Saper J, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics. 2009;123:924–34.PubMedCrossRefGoogle Scholar
  15. 15.
    Borzy JC, Koch TK, Schimschock JR. Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Pediatr Neurol. 2005;33:314–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Campistol J, Campos J, Casas C, Herranz JL. Topiramate in the prophylactic treatment of migraine in children. J Child Neurol. 2005;20:251–3.PubMedGoogle Scholar
  17. 17.
    Aydin M, Kabakus N, Bozdag S, Ertugrul S. Profile of children with migraine. Indian J Pediatr. 2010;77:1247–51.PubMedCrossRefGoogle Scholar
  18. 18.
    Unalp A, Uran N, Oztürk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol. 2008;23:1377–81.PubMedCrossRefGoogle Scholar
  19. 19.
    Lakshmi CV, Singhi P, Malhi P, Ray M. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol. 2007;22:829–35.PubMedCrossRefGoogle Scholar
  20. 20.
    Vollono C, Ferraro D, Valeriani M. Antiepileptic drugs in the preventive treatment of migraine in children and adolescents. Drug Dev Res. 2007;68:355–9.CrossRefGoogle Scholar
  21. 21.
    Ferraro D, Di Trapani G. Topiramate in the prevention of pediatric migraine: literature review. J Headache Pain. 2008;9:147–50.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2013

Authors and Affiliations

  • Razieh Fallah
    • 1
  • Mohammad Saleh Divanizadeh
    • 2
  • Mehran Karimi
    • 3
    • 6
  • Mehrdad Mirouliaei
    • 4
  • Ali Shamszadeh
    • 5
  1. 1.Department of Pediatrics, Research Center of PainShahid Sadoughi University of Medical SciencesYazdIran
  2. 2.Department of PediatricsShahid Sadoughi Hospital, Shahid Sadoughi University of Medical SciencesYazdIran
  3. 3.Department of Pediatrics, Growth Disorders of Children Research CenterShahid Sadoughi University of Medical SciencesYazdIran
  4. 4.Department of PediatricsShahid Sadoughi University of Medical SciencesYazdIran
  5. 5.Department of Computer Engineering, Engineering and Basic Sciences FacultyIslamic Azad University, Sari BranchSariIran
  6. 6.Shahid Sadoughi Hospital, Ave - Sina BlvdYazdIslamic Republic of Iran

Personalised recommendations